Relation of serum phosphorus levels to carotid intima-media thickness in asymptomatic young adults (from the Bogalusa Heart Study).
Increased serum phosphorus has been associated with increased mortality from cardiovascular (CV) disease. However, information is scant regarding the influence of serum phosphorus within the normal range on vascular risk in subclinical atherosclerosis in asymptomatic young adults. Serum phosphorus and other CV risk factor variables were measured in 856 white and 354 black subjects without known CV disease or renal disease. Carotid intima-media thickness (IMT) was measured by B-mode ultrasonography. Significant race and gender differences were noted for serum phosphorus (blacks > whites) and carotid IMT (black women > white women; men > women). In bivariate analyses, serum phosphorus was correlated with carotid IMT (p <0.001), and smokers showed higher phosphorus levels than nonsmokers (p = 0.008). In multivariate regression analyses, carotid IMT was significantly associated with serum phosphorus (regression coefficient beta = 0.028, p <0.001) and smoking (beta = 0.032, p <0.001), adjusting for other CV risk factors and estimated glomerular filtration rate. In addition, a significant interaction effect of cigarette smoking and serum phosphorus on carotid IMT was noted, with a greater increasing trend of carotid IMT with phosphorus in smokers than in nonsmokers (p = 0.019 for interaction). In conclusion, serum phosphorus within the normal range is an important correlate of carotid IMT in asymptomatic young adults, with smoking potentiating this adverse association.
Ruan
Litao
L
Tulane Center for Cardiovascular Health, Tulane University, New Orleans, Louisiana, USA.
Chen
Wei
W
Srinivasan
Sathanur R
SR
Xu
Jihua
J
Toprak
Ahmet
A
Berenson
Gerald S
GS
D000328:Adult; D001741:Black or African American / Q000706:statistics & numerical data; D000465:Algorithms; D050197:Atherosclerosis / Q000150:complications; D015415:Biomarkers / Q000097:blood; D001794:Blood Pressure; D002318:Cardiovascular Diseases / Q000097:blood* / Q000000981:diagnostic imaging* / Q000208:ethnology / Q000209:etiology; D002339:Carotid Arteries / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D008145:Louisiana; D008297:Male; D010758:Phosphorus / Q000097:blood*; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D017539:Tunica Intima / Q000000981:diagnostic imaging*; D017540:Tunica Media / Q000000981:diagnostic imaging*; D014463:Ultrasonography; D044465:White People / Q000706:statistics & numerical data
D015415:Biomarkers; D010758:Phosphorus
Circ Res. 2000 Sep 29;87(7):E10-7
11009570
Int J Epidemiol. 1990 Sep;19(3):559-63
2262248
Am J Physiol Endocrinol Metab. 2001 Mar;280(3):E405-12
11171594
Calcif Tissue Int. 2001 Jun;68(6):358-64
11685424
Ann Intern Med. 2004 Dec 21;141(12):929-37
15611490
J Am Coll Cardiol. 2004 May 19;43(10):1731-7
15145091
J Am Soc Nephrol. 2009 Feb;20(2):397-404
18987306
Kidney Int. 2006 Jul;70(2):351-7
16738536
Circulation. 1997 Sep 16;96(6):1755-60
9323058
Am J Kidney Dis. 1998 Apr;31(4):607-17
9531176
Endocrinology. 1999 Oct;140(10):4683-90
10499526
Arch Intern Med. 2007 May 14;167(9):879-85
17502528
J Neuroimaging. 1991 Nov;1(4):168-72
10149810
Curr Opin Nephrol Hypertens. 2004 Jul;13(4):397-401
15199289
Lancet. 1998 Aug 1;352(9125):391-6
9717944
Cent Eur J Public Health. 1998 Nov;6(4):284-7
9919378
N Engl J Med. 1999 Jan 7;340(1):14-22
9878640
Ann Intern Med. 1998 Feb 15;128(4):262-9
9471928
Circulation. 2005 Oct 25;112(17):2627-33
16246962
Am Heart J. 2008 Sep;156(3):556-63
18760141
Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S56-68
18359409
Clin Chem. 1974 Apr;20(4):470-5
4818200
Atherosclerosis. 2008 Aug;199(2):424-31
18093595
Ren Fail. 2008;30(4):423-9
18569917
Am J Epidemiol. 1997 Sep 15;146(6):483-94
9290509
Diabetologia. 1985 Jul;28(7):412-9
3899825
J Am Soc Nephrol. 2005 Feb;16(2):520-8
15615819